Healthcare & Life Sciences
RheumaGen, Inc.
RheumaGen, Inc. is a Healthcare & Life Sciences startup, most recent round Series A.
series-a
series-a
Stage
About RheumaGen, Inc.
RheumaGen, Inc. is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences.
RheumaGen, Inc. is developing a new class of HLA-targeted gene‑editing therapies to treat major autoimmune diseases. The company launched with a $15 million Series A to advance its HLA gene‑editing therapeutic programs.
Explore RheumaGen, Inc.'s full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.